<!DOCTYPE html>
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>

    <!-- Basic Page Needs
  ================================================== -->
	<meta charset="utf-8">
	<title>Times of Pshychiatry</title>
	<meta name="description" content=" |">
	<meta name="medekahealth" content="">
	
    <!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    
    <!-- CSS
  ================================================== -->
		<link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="../css/responsive.css">
	
	<!--[if lt IE 8]>
       <div style=' clear: both; text-align:center; position: relative;'>
         <a href="http://windows.microsoft.com/en-US/internet-explorer/products/ie/home?ocid=ie6_countdown_bannercode">
           <img src="http://storage.ie6countdown.com/assets/100/images/banners/warning_bar_0000_us.jpg" border="0" height="42" width="820" alt="You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today." />
        </a>
      </div>
    <![endif]-->
    <!--[if lt IE 9]>
		<script src="js/html5.js"></script>
		<script src="js/css3-mediaqueries.js"></script>
	<![endif]-->
	
	<link href='./images/top.ico' rel='icon' type='image/x-icon'/>
  <style type="text/css">
a:hover {
	cursor:pointer; 
}
</style>
<script type="text/javascript">

//SAG scroller demo #1:

var sagscroller1=new sagscroller({
	id:'mysagscroller',
	mode: 'manual' //<--no comma following last option
})

//SAG scroller demo #2:

var sagscroller2=new sagscroller({
	id:'mysagscroller2',
	mode: 'auto',
	pause: 2500,
	animatespeed: 400 //<--no comma following last option
})
     function show(id)
     {
		
        if(document.getElementById(id).style.display == 'none')
        {
              document.getElementById(id).style.display='inline';
			  document.getElementById(id).select();
        }
		else if(document.getElementById(id).style.display == 'inline')
        {
              document.getElementById(id).style.display='none';
        } 
     }
    </script>   
</head>
<body>
<!--------------Header--------------->
<header> 
  <div id="logo"><a href="#"><img src="./images/logo.png"/></a></div>
</header>
<!--------------Navigation--------------->
<nav>
		<!--<ul class="menu">
    	<li><a href="index.html">About TOP</a></li>
		<li><a href="aboutus.html">About us</a></li>
		<li><a href="contact.html">Contact</a></li>
	</ul>-->
	<div class="minimenu"><div>INDEX</div>
		<select onchange="location=this.value">
        <option></option>
			<option value="home.html">Home</option>
			<option value="Amisulpride.html">Amisulpride</option>
			<option value="DER.html">Divalproex extended release</option>
			<option value="MBD.html">Olanzapine</option>
			<option value="EP.html">Escitalopram</option>
			<option value="ZER.html">Zolpidem extended release</option>
            <option value="SCL.html">Scales</option>
			<option value="GDL.html">Guidelines</option>
			<option value="CN.html">Conference news</option>
            <option value="PMS.html">Psychiatry medical app</option>
            <option value="BR.html">Book review</option> 
		</select>
	</div>
</nav>
<!--------------Content--------------->
<section id="content">
	<div id="main-content">
		<article>
			<div class="heading">
				<div class="heading">
				<div class="heading">
				<div style="background-color:#46a1a4; padding:10px; border-radius:10px;"><h11a>Evidence for first-line treatment option for rapid cycling bipolar disorder</h11a><br/>
                <font style="color:#FFF">CANMAT guidelines recommend divalproex as the first-line therapy for rapid cycling bipolar disorder</font></div>
				<div class="info"> by Medeka Health | February 01, 2014</div>
			</div><h12b>Lithium <i>vs</i> divalproex for long-term maintenance</h12b>          
			<div class="content">
			  <p>A 20-month, double-blind, parallel-group
study compared the efficacy of divalproex and
lithium in the management of patients with
recently stabilized rapid-cycling bipolar disorder. In the study, 60 patients were stratified based
on illness type (bipolar I <i>vs</i> bipolar II disorder)
and were randomized to receive either lithium or
divalproex monotherapy in a balanced design.
Findings revealed that:<sup>7</sup></p>
<ul>
<li>Overall, 53% of patients reported a relapse
into any mood; 59% of patients displayed
a depressive relapse, while 41% displayed
hypomanic/manic/mixed relapse</li>
<li>The rates of relapse into any mood episode
were 56 and 50% for patients treated with
lithium and divalproex respectively (<a onMouseOver="cursor:hand;" onClick="javascript:show('vk');"><font color="#46a1a4">Figure 2</font></a>).
<div id="vk" runat="server" style="display: none; text-align: justify; font-size:13px;" >
<a  onMouseOver="cursor:hand;"  onClick="javascript:show('vk');"> <p> <img src="images/DERfig_02.png" alt="Figure 2"></p></a></div></li>
<li>The rate of depressive relapse was 34% for
patients treated with lithium and 29% for
patients treated with divalproex (<a onMouseOver="cursor:hand;" onClick="javascript:show('vk1');"><font color="#46a1a4">Figure 2</font></a>).
<div id="vk1" runat="server" style="display: none; text-align: justify; font-size:13px;" >
<a  onMouseOver="cursor:hand;"  onClick="javascript:show('vk1');"> <p> <img src="images/DERfig_02.png" alt="Figure 2"></p></a></div></li>
<li>The rate of hypomania/mania relapse was
19% for patients treated with lithium and
22% for patients treated divalproex (<a onMouseOver="cursor:hand;" onClick="javascript:show('vk2');"><font color="#46a1a4">Figure 2</font></a>).
<div id="vk2" runat="server" style="display: none; text-align: justify; font-size:13px;" >
<a  onMouseOver="cursor:hand;"  onClick="javascript:show('vk2');"> <p> <img src="images/DERfig_02.png" alt="Figure 2"></p></a></div></li>
<li>The rate of treatment discontinuation due to
side effects was 16% for lithium and 4% for
divalproex (<a onMouseOver="cursor:hand;" onClick="javascript:show('vk8');"><font color="#46a1a4">Figure 2</font></a>).
<div id="vk8" runat="server" style="display: none; text-align: justify; font-size:13px;" >
<a  onMouseOver="cursor:hand;"  onClick="javascript:show('vk8');"> <p> <img src="images/DERfig_02.png" alt="Figure 2"></p></a></div>.</li>
</ul>

 </div>
 <div id="top5">
		<section>
		  <div class="heading">
			<div class="content">
				<ul> <li><a href="DER-I.html">Introduction</a></li>
            <li><a href="DER-II.html">Efficacy of divalproex
monotherapy</a></li>
                <li  style="color:#CCC">Lithium <i>vs</i> divalproex for
long-term maintenance</li>
	<li><a href="DER-IV.html">Summary</a></li>
             <li><a href="DER-V.html">References</a></li>
</ul>
          </div></section></div>
                
          <img src="images/add2.gif" width="575" height="699"/>
		</article>
	</div>
	<div id="sidebar">
		 <section>
		  <div class="heading">
	    <h2>Contents</h2></div>
			<div class="content">
				<ul>
					<li><a href="Amisulpride.html">Amisulpride</a></li>
					<li><a href="DER.html">Divalproex extended release</a></li>
					<li><a href="MBD.html">Olanzapine</a></li>
					<li><a href="EP.html">Escitalopram</a></li>
					<li><a href="ZER.html">Zolpidem extended release</a></li>
					<li><a href="SCL.html">Scales</a></li>
                    <li><a href="GDL.html">Guidelines</a></li>
                    <li><a href="CN.html">Conference news</a></li>
                  <li><a href="PMS.html">Psychiatry medical app</a></li>
                    <li><a href="BR.html">Book review</a></li>
				</ul>
			</div>
		</section>
		<section>
			<div class="heading"><h2>Archives</h2></div>
			<div class="content">
				<ul>
					<li>Present Issue</li>
					<li><a href="../Issue_3/index.html">Previous Issue</a></li>
				</ul>
			</div>
		</section>
	</div>
	<div class="clear"></div>
</section>
<!--------------Footer--------------->
<footer>
	<p>Copyright © 2013 Medekahealth - All rights reserved. | Design by: MedekaHealth</p>
</footer>
</body></html>